These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2527545)

  • 21. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.
    Kobrin I; Ben-Ishay D; Bompani R; Dixon R; Hoverman RJ; Jones RW; Kögler P; Sanchez R
    Am J Med; 1989 Dec; 87(6B):33S-36S. PubMed ID: 2532458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-finding study of cilazapril (Inhibace) in patients with uncomplicated essential hypertension.
    Mroczek WJ; Klein J; Burris JF
    Clin Exp Hypertens A; 1991; 13(8):1415-32. PubMed ID: 1836986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Rosenthal J; Marmor A
    J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four-hour ambulatory noninvasive continuous finger blood pressure measurement with PORTAPRES: a new tool in cardiovascular research.
    Schmidt TF; Wittenhaus J; Steinmetz TF; Piccolo P; Lüpsen H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S117-45. PubMed ID: 1382159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilazapril. A review.
    Szucs T
    Drugs; 1991; 41 Suppl 1():18-24. PubMed ID: 1712267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach.
    Pagani M; Pizzinelli P; Mariani P; Lucini D; di Michele R; Malliani A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S110-6. PubMed ID: 1382158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG; Bolli P; Lee C; Vasdev S
    Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor.
    Goldszer RC; Rodriguez R; Solomon HS
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):300S-302S. PubMed ID: 2970856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function.
    Kloke HJ; Ambros RJ; Van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
    Br J Clin Pharmacol; 1996 Nov; 42(5):615-20. PubMed ID: 8951193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
    Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension.
    Kobrin I; Güntzel P; Viskoper R; Paran E; Zimlichman R
    Drugs; 1991; 41 Suppl 1():31-6. PubMed ID: 1712270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of acute ACE inhibition on atrial natriuretic peptide.
    Doorenbos CJ; van Brummelen P
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):243S-247S. PubMed ID: 2527537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single dose of cilazapril improves diastolic function in hypertensive patients.
    Marmor A; Green T; Krakuer J; Szucs T; Schneeweiss A
    Am J Med; 1989 Dec; 87(6B):61S-63S. PubMed ID: 2532463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
    Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.